glp-1 drugs news today A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio Diabetes: New GLP-1 pill improves

M.AronneL

Many commercial plans now cover semaglutide and tirzepatide when prescribed for weight management, though some insurers still limit approval to diabetes-only indications

These programs often have eligibility requirements, such as income limits or lack of insurance coverage

Therapeutic peptides to treat myocardial ischemia-reperfusion injury

Methods Leveraging the target trial emulation framework, we conducted a retrospective study using observational data to emulate a new user, active comparator trial examining the effects of initiating GLP-1RA (exposure group) versus SGLT2 inhibitors (control group), with random treatment assignment emulated by propensity score matching with 1:1 ratio

Berberine modulates gut microbiota and reduces insulin resistance via the TLR4 signaling pathway